A detailed history of Game Plan Financial Advisors, LLC transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Game Plan Financial Advisors, LLC holds 2,350 shares of ABEO stock, worth $14,570. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,350
Holding current value
$14,570
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$4.12 - $6.32 $9,682 - $14,852
2,350 New
2,350 $14,000

Others Institutions Holding ABEO

About ABEONA THERAPEUTICS INC.


  • Ticker ABEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,950,380
  • Market Cap $36.9M
  • Description
  • Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...
More about ABEO
Track This Portfolio

Track Game Plan Financial Advisors, LLC Portfolio

Follow Game Plan Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.